Sanjivani Paranteral Ltd — Important, 16-02-2026: Company Update

Sanjivani Paranteral Limited reported strong financial results for the third quarter and nine months. Standalone revenue from operations rose 20.25% year-on-year to Rs. 20.86 Cr, with Profit After Tax (PAT) growing 37.8% to Rs. 2.62 Cr. Consolidated revenue increased 27.17% to Rs. 22.06 Cr, and PAT climbed 46.2% to Rs. 2.78 Cr. This performance was driven by the first-time contribution from SPL Infusion's Pune facility, expanding manufacturing capabilities and strengthening topline growth. Oral product revenue surged 153.5%, with exports making up 76.9% of total revenue.